Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217522 · ClinicalTrials.gov registry record
Rutgers University Study of the Genetics of Pulmonary Hypertension
A clinical trial of Pulmonary Hypertension and Pulmonary Arterial Hypertension, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT07217522: Recruiting study of Pulmonary Hypertension and Pulmonary Arterial Hypertension, sponsored by Rutgers, The State University of New Jersey.
NCT07217522 is a study of Pulmonary Hypertension and Pulmonary Arterial Hypertension that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 10,000 participants, above the 475-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (2005% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217522, a study of Pulmonary Hypertension and Pulmonary Arterial Hypertension, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Primary Outcome
Genetic factors will be measured through whole exome sequencing along with genotyping of common variants, and then correlated with pulmonary hypertension and pulmonary hypertension subtype.
Conditions Studied
Interventions
- GENETIC Saliva sample
- OTHER Health surveys
Study Locations (1)
New Jersey
- Rutgers University, Piscataway, New Jersey 08854 - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2025-08-23 |
| Est. Completion | 2027-12-31 |
What NCT07217522 shows while recruiting
NCT07217522 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 475-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (2005% higher).
The record links to 8 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Saliva sample is the first listed.
NCT07217522 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07217522 about?
NCT07217522 is a clinical study titled "Rutgers University Study of the Genetics of Pulmonary Hypertension". The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request...
What is the current status of trial NCT07217522?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2025-08-23. Estimated completion is 2027-12-31.
What conditions does trial NCT07217522 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder), Pulmonary Arterial Hypertension Associated With Connective Tissue Disease, Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH).
What interventions are being tested in trial NCT07217522?
The interventions under investigation include: Saliva sample (GENETIC), Health surveys (OTHER).
Who is sponsoring clinical trial NCT07217522?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217522 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07217522's enrollment target sits among peer trials
10,000 1st of 72 higher than 72 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI